Olivera Casar-Borota Selected Research

Olivera Casar-Borota Research Topics

Disease

14	Neoplasms (Cancer) 03/2024 - 08/2013
9	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 02/2012
7	Adenoma (Adenomas) 05/2016 - 12/2011
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021 - 09/2017
5	Acromegaly 07/2016 - 01/2012
3	Growth Hormone-Secreting Pituitary Adenoma 07/2016 - 09/2013
2	Paraganglioma (Paragangliomas) 01/2021 - 08/2016
2	ACTH-Secreting Pituitary Adenoma 08/2013 - 12/2011
1	Immunoglobulin G4-Related Disease 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	alpha-Thalassemia 01/2021
1	Intellectual Disability (Idiocy) 01/2021
1	Drug Resistant Epilepsy 01/2020
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2018
1	Craniopharyngioma (Craniopharyngiomas) 11/2017
1	Carcinoma (Carcinomatosis) 09/2017
1	Glioma (Gliomas) 08/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2016
1	Carcinogenesis 08/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2016
1	Headache (Headaches) 10/2015
1	Muscular Diseases (Myopathy) 04/2015
1	Congenital Structural Myopathies (Centronuclear Myopathy) 04/2015
1	type 1 Pena Shokeir syndrome 03/2015
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 03/2015
1	Pituitary ACTH Hypersecretion 12/2011

Drug/Important Bio-Agent (IBA)

7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 01/2012
5	Hormones (Hormone)IBA 11/2021 - 02/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2011
4	Messenger RNA (mRNA)IBA 03/2024 - 12/2011
4	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 11/2013
3	Cadherins (E-Cadherin)IBA 01/2020 - 12/2011
3	Growth Hormone (Somatotropin)IBA 05/2016 - 02/2012
3	Octreotide (Sandostatin)FDA LinkGeneric 10/2015 - 07/2012
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2015
2	RNA (Ribonucleic Acid)IBA 09/2013 - 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	MTOR InhibitorsIBA 01/2020
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2020
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2020
1	Edotreotide (SMT 487)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	Anterior Pituitary HormonesIBA 04/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	trametinibIBA 11/2017
1	dabrafenibIBA 11/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017
1	Serotonin (5 Hydroxytryptamine)IBA 09/2017
1	Estrogen ReceptorsIBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	somatostatin receptor type 1IBA 01/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2016
1	EnzymesIBA 08/2016
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2016
1	GalactosidasesIBA 03/2016
1	Analgesics (Analgesic Drugs)IBA 10/2015
1	somatostatin receptor 5IBA 10/2015
1	Insulin-Like PeptidesIBA 10/2015
1	pasireotideIBA 10/2015
1	Dynamin IIIBA 04/2015
1	muskIBA 03/2015
1	Monoclonal AntibodiesIBA 11/2013
1	somatostatin receptor 2IBA 11/2013
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2013
1	GlucocorticoidsIBA 08/2013
1	Imatinib Mesylate (Gleevec)FDA Link 02/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2012
1	GuanosineIBA 12/2011
1	CytosineIBA 12/2011
1	Phosphates (Orthophosphate)IBA 12/2011

Therapy/Procedure

5	Therapeutics 01/2023 - 10/2015
1	Radiotherapy 01/2020
1	Neoadjuvant Therapy 11/2017